blank Quick help
blank Maintenance news

Scheduled maintenance

Regular maintenance outages:
between 05.00 and 05.15 hrs CET (Monday to Sunday).

Other outages
Availability
Register Forum

2022.02.11

More...
blank News flashes

News Flashes

New version of the European Patent Register – SPC proceedings information in the Unitary Patent Register.

2024-07-24

More...
blank Related links

Release notes
European Patent Register Assistant
European Patent Register Resource Book
European Patent Register – pocket guide
FAQ - European Patent Register
FAQ - Register Alert
Federated Register (Flyer)
Global Dossier (Flyer)
Register events
Deep link coverage
Federated Register content
The Patent Information Tour
Fair use charter

Extract from the Register of European Patents

EP About this file: EP2594279

EP2594279 - Tissue protective peptides and uses thereof [Right-click to bookmark this link]
StatusNo opposition filed within time limit
Status updated on  28.09.2018
Database last updated on 24.08.2024
FormerThe patent has been granted
Status updated on  20.10.2017
FormerGrant of patent is intended
Status updated on  04.07.2017
Most recent event   Tooltip19.04.2019Lapse of the patent in a contracting state
New state(s): LU		published on 22.05.2019  [2019/21]
Applicant(s)For all designated states
Araim Pharmaceuticals, Inc.
580 White Plains Road, Suite 210
Tarrytown, NY 10591 / US
[2015/11]
Former [2013/21]For all designated states
Araim Pharmaceuticals, Inc.
712 Kitchawan Road
Ossining, NY 10562 / US
Inventor(s)01 / Cerami, Anthony
c/o Araim Pharmaceuticals, Inc.
712 Kitchawan Road
Ossining, NY 10562 / US
02 / Brines, Michael
c/o Araim Pharmaceuticals, Inc.
712 Kitchawan Road
Ossining, NY 10562 / US
03 / Coleman, Thomas
c/o Araim Pharmaceuticals, Inc.
712 Kitchawan Road
Ossining, NY 10562 / US
 [2013/21]
Representative(s)Jones Day
Rechtsanwälte, Attorneys-at-Law, Patentanwälte
Prinzregentenstrasse 11
80538 München / DE
[N/P]
Former [2013/52]Savic, Bojan, et al
Jones Day
Rechtsanwälte Attorneys-at-Law Patentanwälte
Prinzregentenstraße 11
80538 München / DE
Former [2013/21]Ritter, Thomas Kurt, et al
Jones Day
Prinzregentenstraße 11
80538 München / DE
Application number, filing date12175366.907.08.2006
[2013/21]
Priority number, dateUS20050705741P05.08.2005         Original published format: US 705741 P
US20050706276P08.08.2005         Original published format: US 706276 P
US20060831737P18.07.2006         Original published format: US 831737 P
[2013/21]
Filing languageEN
Procedural languageEN
PublicationType: A1 Application with search report 
No.:EP2594279
Date:22.05.2013
Language:EN
[2013/21]
Type: B1 Patent specification 
No.:EP2594279
Date:22.11.2017
Language:EN
[2017/47]
Search report(s)(Supplementary) European search report - dispatched on:EP23.04.2013
ClassificationIPC:A61K38/00
[2013/21]
CPC:
A61P1/00 (EP); C07K14/435 (KR,US); C07K14/505 (CN,KR,US);
A61K38/00 (EP,CN,KR,US); A61P1/04 (EP); A61P11/00 (EP);
A61P13/00 (EP); A61P13/12 (EP); A61P15/00 (EP);
A61P15/08 (EP); A61P17/00 (EP); A61P17/02 (EP);
A61P19/00 (EP); A61P19/08 (EP); A61P25/00 (EP);
A61P25/02 (EP); A61P25/28 (EP); A61P27/02 (EP);
A61P29/00 (EP); A61P3/00 (EP); A61P3/10 (EP);
A61P33/06 (EP); A61P37/02 (EP); A61P39/00 (EP);
A61P43/00 (EP); A61P5/00 (EP); A61P7/00 (EP);
A61P7/04 (EP); A61P9/00 (EP); A61P9/04 (EP);
A61P9/10 (EP); A61P9/14 (EP); C07K14/575 (KR,US);
C07K14/71 (EP,KR,US); C07K2319/00 (KR,US); Y02A50/30 (EP,US) (-)
Designated contracting statesAT,   BE,   BG,   CH,   CY,   CZ,   DE,   DK,   EE,   ES,   FI,   FR,   GB,   GR,   HU,   IE,   IS,   IT,   LI,   LT,   LU,   LV,   MC,   NL,   PL,   PT,   RO,   SE,   SI,   SK,   TR [2017/47]
Former [2013/21]AT,  BE,  BG,  CH,  CY,  CZ,  DE,  DK,  EE,  ES,  FI,  FR,  GB,  GR,  HU,  IE,  IS,  IT,  LI,  LT,  LU,  LV,  MC,  NL,  PL,  PT,  RO,  SE,  SI,  SK,  TR 
Extension statesAL18.11.2013
BA18.11.2013
HR18.11.2013
MK18.11.2013
RS18.11.2013
TitleGerman:Gewebeschützende Peptide und ihre Verwendung[2013/21]
English:Tissue protective peptides and uses thereof[2013/21]
French:Peptides protecteurs de tissus et utilisations associées[2013/21]
Examination procedure18.11.2013Examination requested  [2013/52]
10.01.2014Despatch of communication that the application is deemed to be withdrawn, reason: reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report not received in time
19.03.2014Amendment by applicant (claims and/or description)
10.08.2015Despatch of a communication from the examining division (Time limit: M04)
04.12.2015Reply to a communication from the examining division
19.06.2017Cancellation of oral proceeding that was planned for 21.06.2017
21.06.2017Date of oral proceedings (cancelled)
05.07.2017Communication of intention to grant the patent
11.10.2017Fee for grant paid
11.10.2017Fee for publishing/printing paid
11.10.2017Receipt of the translation of the claim(s)
Parent application(s)   TooltipEP06801051.1  / EP1924276
EP11163194.1  / EP2371855
Opposition(s)23.08.2018No opposition filed within time limit [2018/44]
Request for further processing for:The application is deemed to be withdrawn due to failure to reply to the Extended European Search Report/Written Opinion of the International Searching Authority/International Preliminary Examination Report/Supplementary international search report/Supplementary European search report
19.03.2014Request for further processing filed
19.03.2014Full payment received (date of receipt of payment)
Request granted
27.03.2014Decision despatched
Fees paidRenewal fee
29.10.2012Renewal fee patent year 03
29.10.2012Renewal fee patent year 04
29.10.2012Renewal fee patent year 05
29.10.2012Renewal fee patent year 06
28.08.2012Renewal fee patent year 07
19.08.2013Renewal fee patent year 08
13.08.2014Renewal fee patent year 09
10.08.2015Renewal fee patent year 10
11.08.2016Renewal fee patent year 11
14.08.2017Renewal fee patent year 12
Opt-out from the exclusive  Tooltip
competence of the Unified
Patent Court		 See the Register of the Unified Patent Court for opt-out data
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court.
Lapses during opposition  TooltipCY22.11.2017
EE22.11.2017
LV22.11.2017
MC22.11.2017
BG22.02.2018
LU07.08.2018
[2019/21]
Former [2019/15]CY22.11.2017
EE22.11.2017
LV22.11.2017
MC22.11.2017
BG22.02.2018
Former [2018/37]CY22.11.2017
EE22.11.2017
LV22.11.2017
BG22.02.2018
Documents cited:Search[A]EP0116446  (AMGEN [US]) [A] 1-22 * see Claim 4, peptide P4 *;
 [Y]  - GHEZZI P ET AL, "Erythropoietin as an antiapoptotic, tissue-protective cytokine", CELL DEATH AND DIFFERENTIATION, (200407), vol. 11, no. Suppl. 1, ISSN 1350-9047, pages S37 - S44, XP002695050 [Y] 1-4,6-22 * the whole document *

DOI:   http://dx.doi.org/10.1038/sj.cdd.4401450
 [YP]  - KAISER KARINE ET AL, "Recombinant human erythropoietin prevents the death of mice during cerebral malaria", JOURNAL OF INFECTIOUS DISEASES, (200604), vol. 193, no. 7, ISSN 0022-1899, pages 987 - 995, XP002695051 [YP] 1-4,6-22 * the whole document *

DOI:   http://dx.doi.org/10.1086/500844
 [Y]  - LEIST M ET AL, "DERIVATIVES OF ERYTHROPOIETIN THAT ARE TISSUE PROTECTIVE BUT NOT ERYTHROPOIETIC", SCIENCE, AMERICAN ASSOCIATION FOR THE ADVANCEMENT OF SCIENCE, WASHINGTON, DC; US, (20040709), vol. 305, no. 5681, doi:10.1126/SCIENCE.1098313, ISSN 0036-8075, pages 239 - 243, XP002346906 [Y] 1-4,6-22 * the whole document *

DOI:   http://dx.doi.org/10.1126/science.1098313
by applicantUS4704355
 US4798824
 WO9104014
 US5051448
 US5192746
 US5559103
 US5571787
 US5576423
 US5696080
 US5700909
 US5714459
 WO02053580
 US2003072737
 WO2004022577
 WO2004096148
 WO2005025606
 WO2005032467
    - CHEETHAM ET AL., NAT. STRUCT. BIOL., (1998), vol. 5, pages 861 - 866
    - MURRAY, Harpers Biochemistry 24th ed., APPILION & LANGE, LTD., (1996), pages 524 - 526
    - CARAVELLA ET AL., PROTEIN: STRUCT. FUNCT. GEN., (1996), vol. 24, pages 394 - 401
    - CHEETHAM ET AL., NATURE STRUCTURAL BIOLOGY, (1998), vol. 5, pages 861 - 866
    - KIRITO ET AL., BLOOD, (2002), vol. 99, pages 102 - 110
    - LIVNAH ET AL., SCIENCE, (1999), vol. 283, pages 987 - 990
    - NARANDA ET AL., ENDOCRINOLOGY, (2002), vol. 143, pages 2293 - 2302
    - REMY, SCIENCE, (1999), vol. 283, pages 990 - 993
    - YOSHIMURA ET AL., THE ONCOLOGIST, (1996), vol. 1, pages 337 - 339
    - COLEMAN ET AL., PNAS, (2006), vol. 103, pages 5965 - 5970
    - SEGREST, PROTEINS, (1990), vol. 8, pages 103 - 117
    - CAMPANA ET AL., INT. J. MOL. MED., (1998), vol. 1, no. 1, pages 235 - 241
    - KANNAN, NEUROIMMUNOMOD, (2000), vol. 8, pages 132 - 141
    - NILSSON, B.; SOELLNER, M.; RAINES, R., "Chemical Synthesis of Proteins", ANNU. REV. BIOMOL. STRUCT., (2005), vol. 34, pages 91 - 118, XP008067415
    - MELDAL M., "Properties of solid supports", METHODS ENZYMOL., (1997), vol. 289, doi:doi:10.1016/S0076-6879(97)89045-3, pages 83 - 104, XP001154372

DOI:   http://dx.doi.org/10.1016/S0076-6879(97)89045-3
    - SONGSTER MF; BARANY G., "Handles for solid-phase peptide synthesis", METHODS ENZYMOL., (1997), vol. 289, doi:doi:10.1016/S0076-6879(97)89047-7, pages 126 - 74, XP009037496

DOI:   http://dx.doi.org/10.1016/S0076-6879(97)89047-7
    - WELLINGS DA; ATHERTON E., "Standard Fmoc protocols", METHODS ENZYMOL., (1997), vol. 289, doi:doi:10.1016/S0076-6879(97)89043-X, pages 44 - 67, XP000921014

DOI:   http://dx.doi.org/10.1016/S0076-6879(97)89043-X
    - METHODS ENZYMOL., vol. 289, pages 67 - 83
    - STEWART JM., "Cleavage methods following Boc-based solid-phase peptide synthesis", METHODS ENZYMOL., (1997), vol. 289, doi:doi:10.1016/S0076-6879(97)89042-8, pages 29 - 44, XP009116686

DOI:   http://dx.doi.org/10.1016/S0076-6879(97)89042-8
    - BANG, D.; KENT, S., "A One-Pot Total Synthesis of Crambin", ANGEW. CHEM. INT. ED., (2004), vol. 43, doi:doi:10.1002/anie.200353540, pages 2534 - 2538, XP002446157

DOI:   http://dx.doi.org/10.1002/anie.200353540
    - BANG, D.; CHOPRA, N.; KENT, S., "Total Chemical Synthesis of Crambin", J. AM. CHEM. SOC., (2004), vol. 126, doi:doi:10.1021/ja0385078, pages 1377 - 1383, XP008148467

DOI:   http://dx.doi.org/10.1021/ja0385078
    - DAWSON, P. ET AL., "Synthesis of Proteins by Native Chemical Ligation", SCIENCE, (1994), vol. 266, doi:doi:10.1126/science.7973629, pages 776 - 779, XP002064666

DOI:   http://dx.doi.org/10.1126/science.7973629
    - KOCHENDOERFER ET AL., "Design and Chemical Synthesis of a Homogenous Polymer-Modified Erythropoiesis Protein", SCIENCE, (2003), vol. 299, doi:doi:10.1126/science.1079085, pages 884 - 887, XP002325217

DOI:   http://dx.doi.org/10.1126/science.1079085
    - SIMON ET AL., "Peptoids: A molecular approach to drug discovery", PROC. NATL. ACAD. SCI USA, (1992), vol. 89, pages 9367 - 9371
    - LI ET AL., "Photolithographic Synthesis of Peptoids", J. AM. CHEM. SOC., (2004), vol. 126, pages 4088 - 4089
    - FAUCHERE, J., ADV. DRUG RES., (1986), vol. 15, page 29
    - VEBER; FRIEDINGER, TINS, (1985), page 32
    - EVANS ET AL., J. MED. CHEM, (1987), vol. 30, page 1229
    - Methods of Organic Chemistry (Houben-Weyl), Sythesis of Peptides and Peptidomimetics - Workbench, GEORGE THIEME VERLAG, (2004), vol. E22C
    - Methods of Organic Chemistry (Houben-Weyl), Synthesis of Peptides and Peptidomimetics - Workbench, GEORGE THIEME VERLAG, (2004), vol. E22C
    - CHRISTOPHER J. NOREN; SPENCER J; ANTHONY-CAHILL; MICHAEL C. GRIFFITH; PETER G. SCHULTZ, SCIENCE, (1989), vol. 244, pages 182 - 188
    - SPATOLA, A.F., Chemistry and Biochemistry of Amino Acids, Peptides, and Proteins, MARCEL DEKKER, (1983), page 267
    - SPATOLA, A.F., "Peptide Backbone Modifications", VEGA DATA, (198303), vol. 1, no. 3
    - MORELY, J.S., TRENDS PHARMA SCI, (1980), pages 463 - 468
    - HUDSON, D. ET AL., INT J PEPT PROT RE, (1979), vol. 14, pages 177 - 185
    - SPATOLA, A.F. ET AL., LIFE SCI, (1986), vol. 38, pages 1243 - 1249
    - HANN, M. M., J CHEM SOC PERKIN TRANS I, (1982), pages 307 - 314
    - ALMQUIST, R. G. ET AL., J MED CHEM, (1980), vol. 23, page 1392
    - JENNINGS-WHITE, C ET AL., TETRAHEDRON LETT, (1982), vol. 23, page 2533
    - SZELKE, M ET AL., EUROPEAN APPLN. EP 45665 (1982) CA, (1982), vol. 97, page 39405
    - HOLLADAY, M. W. ET AL., TETRAHEDRON LETT, (1983), vol. 24, pages 4401 - 4404
    - HRUBY, V.J., LIFE SCI, (1982), vol. 31, pages 189 - 199
    - ELDRED ET AL., J. MED. CHEM., (1994), vol. 37, page 3882
    - LIKEWISE, KU ET AL., J. MED. CHEM, (1995), vol. 38, page 9
    - SUN ET AL., PNAS, (2001), vol. 98, pages 15306 - 15311
    - SCHMID ET AL., J. BIOL. CHEM., (2003), vol. 276, pages 1932 - 1935
    - PESCE ET AL., EMBO, (2002), vol. 3, pages 1146 - 1151
    - SRIVASTAVA; POLLARD, FASEB J., (1999), vol. 13, pages 1911 - 1922
    - GINISTY ET AL., J. CELL SCI., (1999), vol. 112, pages 761 - 772
    - STURM ET AL., EUR J CLIN INVEST, (2005), vol. 35, page 711
    - LEIST ET AL., SCIENCE, (2004), vol. 305, pages 239 - 242
    - BRINES ET AL., PNAS, (2000), vol. 97, pages 10295 - 10672
    - ROSENBAUM ET AL., VIS. RES., (1997), vol. 37, pages 3443 - 51
    - CALVILLO ET AL., PNAS, (2003), vol. 100, pages 4802 - 4806
    - FIORDALISO ET AL., PNAS, (2005), vol. 102, pages 2046 - 2051
    - GRASSO ET AL., MED SCI MONIT, (2004), page 10
    - MOSMAN, J. IMMUNOL. METH., (1983), vol. 65, pages 55 - 63
    - TSAI ET AL., J. NEUROSCI, (2006), vol. 26, pages 1269 - 74
    - BAHLMANN ET AL., KIDNEY INT., (2003), vol. 64, pages 1648 - 1652
    - SEFTON, CRC CRIT. REF. BIOMED. ENG., (1987), vol. 14, page 201
    - BUCHWALD ET AL., SURGERY, (1980), vol. 88, page 507
    - SAUDEK ET AL., N. ENGL. J. MED., (1989), vol. 321, page 574
    - LANGER, SCIENCE, (1990), vol. 249, pages 1527 - 1533
    - TREAT ET AL., Liposomes in the Therapy of Infectious Disease and Cancer, LISS, (1989), pages 353 - 365
    - RANGER; PEPPAS, J. MACROMOL. SCI. REV. MACROMOL. CHEM., (1953), vol. 23, page 61
    - LEVY ET AL., SCIENCE, (1985), vol. 228, page 190
    - DURING ET AL., ANN. NEUROL., (1989), vol. 25, page 351
    - HOWARD ET AL., J. NEUROSURG., (1989), vol. 71, page 105
    - GOODSON, MEDICAL APPLICATIONS OF CONTROLLED RELEASE, (1984), vol. 2, pages 115 - 138
    - POZNANSKY ET AL., SCIENCE, (1984), vol. 223, pages 1304 - 1306
    - CARLSSON ET AL., BIOCHEM J., (1978), vol. 173, pages 723 - 737
    - CARLSSON, J. ET AL., BIOCHEM. J., (1978), vol. 173, pages 723 - 737
    - CUMBER, J.A. ET AL., METHODS IN ENZYMOLOGY, (1985), vol. 112, pages 207 - 224
    - JUE, R. ET AL., BIOCHEM, (1978), vol. 17, pages 5399 - 5405
    - SUN, T.T. ET AL., BIOCHEM., (1974), vol. 13, pages 2334 - 2340
    - BLATTLER, W.A. ET AL., BIOCHEM., (1985), vol. 24, pages 1517 - 152
    - LIU, F.T. ET AL., BIOCHEM., (1979), vol. 18, pages 690 - 697
    - YOULE, R.J.; NEVILLE, D.M. JR., PROC. NATL. ACAD. SCI. U.S.A., (1980), vol. 77, pages 5483 - 5486
    - LERNER, R.A. ET AL., PROC. NATL. ACAD. SCI. U.S.A., (1981), vol. 78, pages 3403 - 3407
    - JUNG, S.M.; MOROI, M., BIOCHEM. BIOPHYS. ACTA, (1983), vol. 761, page 162
    - CAULFIELD, M.P. ET AL., BIOCHEM., (1984), vol. 81, pages 7772 - 7776
    - STAROS, J.V., BIOCHEM., (1982), vol. 21, pages 3950 - 3955
    - YOSHITAKE, S. ET AL., EUR. J. BIOCHEM., (1979), vol. 101, pages 395 - 399
    - YOSHITAKE, S. ET AL., J. BIOCHEM., (1982), vol. 92, pages 1413 - 1424
    - PILCH, P.F.; CZECH, M.P., J. BIOL. CHEM., (1979), vol. 254, pages 3375 - 3381
    - NOVICK, D. ET AL., J. BIOL. CHEM., (1987), vol. 262, pages 8483 - 8487
    - LOMANT, A.J.; FAIRBANKS, G., J. MOL. BIOL., (1976), vol. 104, pages 243 - 261
    - HAMADA, H.; TSURUO, T., ANAL. BIOCHEM., (1987), vol. 160, pages 483 - 488
    - HASHIDA, S. ET AL., J. APPLIED BIOCHEM., (1984), vol. 6, pages 56 - 63
    - MEANS; FEENEY, BIOCONJUGATE CHEM., (1990), vol. 1, pages 2 - 12
    - BAND, D.; CHOPRA, N; KENT, S., "Total Synthesis ofCrambin", J.AM. CHEM. SOC., (2004), vol. 126, pages 1377 - 1383
    - S. ERBAYRAKTAR ET AL., PROC NATL ACAD SCI USA, (2003), vol. 100, pages 6741 - 6746
    - SIREN ET AL., PNAS, (2001), vol. 98, page 4044
    - BRINES ET AL., PNAS USA, (2000), vol. 97, pages 10526 - 10531
    - MARKGRAF ET AL., BRAIN RESEARCH, (1992), vol. 575, pages 238 - 246
    - BIANCHI ET AL., PROC NATL ACAD SCI USA, (2004), vol. 101, pages 823 - 828
    - BIANCHI ET AL., CLIN CANCER RES, (2006), vol. 12, pages 2607 - 2612
    - XU ET AL., INVEST. OPHTHAL. VIS. SCI, (2001), vol. 42, pages 789 - 794
    - SHARPLES ET AL., J AMER SOC NEPHROL, (2005), vol. 15, page 2115
    - KAISER ET AL., J. INFECT. DIS., (2006), vol. 193, pages 987 - 995
    - SAVINO ET AL., J NEUROIMMUNOL, (2006), vol. 172, pages 27 - 37
 US20060266503
 WO2001US49479
 US20020185841
 WO2003US20964
The EPO accepts no responsibility for the accuracy of data originating from other authorities; in particular, it does not guarantee that it is complete, up to date or fit for specific purposes.